Table 1 Clinical markers, symptoms and quality of life
Control period (no fiber added) | Intervention period with added fiber | P value | |
|---|---|---|---|
Weight (kg) | 89 ± 6 | 90 ± 6 | NS |
Clinical markers | |||
Glucose mg/dL | 136 ± 29 | 146 ± 25 | NS |
LDL mg/dL | 100 ± 8 | 93 ± 7 | P = 0.05 |
HDL mg/dL | 47 ± 4 | 47 ± 4 | NS |
Total CHOL mg/dL | 175 ± 12 | 167 ± 11 | P = 0.02 |
TG mg/dL | 165 ± 21 | 154 ± 21 | NS |
CHOL:HDL ratio | 4.0 ± 0.3 | 3.7 ± 0.2 | P = 0.02 |
KDQOL-36™ | |||
Symptom/Problem list | 78 ± 3 | 80 ± 3 | NS |
Effects of kidney disease | 84 ± 4 | 87 ± 3 | NS |
Burden of kidney disease | 67 ± 6 | 73 ± 6 | NS |
Physical component summary | 31 ± 2 | 35 ± 3 | P = 0.02 |
Mental component summary | 53 ± 2 | 48 ± 2 | P = 0.01 |
Overall mean scores | 63 ± 3 | 64 ± 3 | NS |
Symptoms | |||
SNAQ | 14 ± 1 | 14 ± 1 | NS |
GSRS | 23 ± 1 | 22 ± 1 | NS |
ESS | 10 ± 1 | 8 ± 1 | P = 0.04 |
Stool frequency | 1.3 ± 0.2 | 1.6 ± 0.2 | P = 0.02 |